Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MilliporeSigma's Single-use Technologies for Flexible Mfg. | Contract Pharma

What are you searching for?

Sign in
Breaking News

MilliporeSigma’s Single-use Technologies for Flexible Mfg.

Innovations include single-use tangential flow filtration capsule for bioprocessing of ADCs and monoclonal antibodies

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

MilliporeSigma has introduced three new products to support flexible manufacturing of biologics. The innovations, all designed to make single-use bioprocessing easier, safer and more efficient, were unveiled at Interphex 2018, held April 17-19 in New York City.

The new products include:
• Pellicon Capsule with Ultracel Membrane, a first-of-its kind single-use tangential flow filtration device that advances flexible manufacturing;
• Millipak Final Fill Filter, for high-value, small-volume processing; and
• Mobius Power MIX 2,500-Liter and 3,000-Liter large-scale single-use mixers.

“The biopharmaceutical industry needs flexible manufacturing solutions that reduce long drug development timelines and accommodate shifts in demand, while protecting employees and the environment,” said Andrew Bulpin, head of process solutions, MilliporeSigma. “MilliporeSigma’s new bioprocessing innovations demonstrate our commitment to developing superior single-use technologies that will drive implementation of flexible manufacturing technologies around the world.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters